Platelet rich fibrin and commercial sealants for dural closure in neurosurgery: An in vitro study
PLOS ONE · 01.04.2025 · 20 (4) · e0319349
DOI: 10.1371/journal.pone.0319349 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 01.04.2025. Verfasst von Katerina Argiti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Dura Mater, Neurosurgical Procedures, Platelet-Rich Fibrin, Tissue Adhesives. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Watertight closure of the dura mater is essential after neurosurgical interventions to avoid complications such meningitis, intracranial hypotension and surgical site infections. In addition to conventional suturing techniques, various biomaterials have been proposed as sealants to minimize the risk of leakage. We previously reported that patient derived platelet-rich fibrin (PRF), an autologous biomaterial, significantly improves watertight dural closure when applied as an onlay over a standard running suture. To demonstrate the efficacy of this method, we aimed to compare this orthobiological approach with other commercially available sealants.
Methods
We utilized an in vitro testing device that allowed for the assessment of watertight dura mater closure via hydrostatic testing. On our testing phantom using freshly harvested bovine dura maters, a standardized 20-mm incision was closed using a running suture, and the leak pressure was measured initially without (primary leak pressure) and subsequently with on lay augmentation (secondary leak pressure) using either PRF, fibrinogen- and thrombin-coated collagen patch (TachoSil®), collagen matrix graft (DuraGen®), Polyethylenglykol (PEG) and polyethylene glycol ester and trilysine amine hydrogel solution (DuraSeal®), polyethylene glycol, protein-reactive polyethylene glycol monomer coated collagen matrix (Hemopatch®) or polyethylenimine component autospray sealant (Adherus®).
Results
The outcomes demonstrate that the usage of a dural onlay in addition to the standard running suture exhibited a substantial improvement in leak pressure compared to the running suture alone. Specifically, the median leak pressure was improved by 3.5 times, where the combined approach was able to withstand 38 cm H 2 O, whereas the running suture alone had a median leak pressure of 11 cm H 2 O. Upon evaluating the performance of the sealants, we identified two categories of dural sealants: a medium performance group (30 ± 2 cm H 2 O) comprised of Adherus® (31 cm H 2 O), DuraGen® (31 cm H 2 O), and Hemopatch® (28 cm H 2 O), and a high-performance group composed of DuraSeal® (45.5 cm H 2 O), and TachoSil® (41 cm H 2 O). Patient-derived PRF was able to withstand a max pressure of 45 cm H 2 O, falling into the high-performance group. Of all the sealants tested in this study, the PRF based patch demonstrated the lowest variance in leak pressure among all the tested sealants.
Conclusions
Autologous platelet-rich fibrin in a two-step procedure displayed enhanced augmentation and reinforced watertight closure of the dura mater, exhibiting a four-fold increase in leak pressure compared to standard running suture alone. Among other commonly utilized commercial sealants, it ranked second with demonstrated consistency in its performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Medical Faculty, University of Freiburg, Freiburg, Germany.
- Laboratory of Experimental Brain & Spine Surgery (LENS), Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Daniel Strahnen, Ioannis Vasilikos
Zitieren
APA
Argiti, K., Shah, M. J., Joseph, K., Ravi, V. M., Stathi, A., Volz, F., El Rahal, A., Strahnen, D., Grauvogel, J., Rölz, R., Hubbe, U., Beck, J., & Vasilikos, I. (2025). Platelet rich fibrin and commercial sealants for dural closure in neurosurgery: An in vitro study. PLOS ONE, 20(4), e0319349. https://doi.org/10.1371/journal.pone.0319349
Vancouver
Argiti K, Shah MJ, Joseph K, Ravi VM, Stathi A, Volz F, et al. Platelet rich fibrin and commercial sealants for dural closure in neurosurgery: An in vitro study. PLOS ONE. 2025;20(4):e0319349. doi:10.1371/journal.pone.0319349
BibTeX
@article{Argiti2025,
author = {Argiti, Katerina and Shah, Mukesch J and Joseph, Kevin and Ravi, Vidhya M and Stathi, Angeliki and Volz, Florian and El Rahal, Amir and Strahnen, Daniel and Grauvogel, Jürgen and Rölz, Roland and Hubbe, Ulrich and Beck, Jürgen and Vasilikos, Ioannis},
title = {Platelet rich fibrin and commercial sealants for dural closure in neurosurgery: An in vitro study},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {4},
pages = {e0319349},
doi = {10.1371/journal.pone.0319349}
}
EUVIMED